Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

AMBIEN 5 MG TABLET

zolpidem tartrate
$20.6203per EA
High Outlier
DEA Schedule CIV

Strength

5 mg/1

Manufacturer

Sanofi-Aventis U.S. LLC

NDC

00024540131

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

2/19/2025

Active Ingredients

ZOLPIDEM TARTRATE

Approval Type

New Drug (NDA)

FDA Application

NDA019908

On Market Since

4/1/1993

Pharmacological Classes

Central Nervous System Depression
GABA A Receptor Positive Modulators
gamma-Aminobutyric Acid A Receptor Positive Modulator

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

+0.1%

5Y

+10.1%

All

+113.7%

Generic Alternatives

Save up to 100%

3 alternatives • Same active ingredient

ZOLPIDEM TARTRATE 5 MG TABLET
Generic
13668000790•Torrent Pharmaceuticals Limited
$0.0280
Save 100%
ZOLPIDEM TARTRATE 5 MG TABLET
Generic
00904608261•Major Pharmaceuticals
$0.0347
Save 100%
AMBIEN 5 MG TABLET
Brand
00713540101•Cosette Pharmaceuticals, Inc.
$20.6203

Related Drugs

Same classification

EDLUAR 10 MG SL TABLET
Brand
00037601093•Viatris Specialty LLC
$15.5590
per EA
XCOPRI 25 MG TABLET
Brand
71699002530•SK Life Science, Inc.
$39.8682
per EA
XCOPRI 50 MG TABLET
Brand
71699005030•SK Life Science, Inc.
$39.8997
per EA
XCOPRI 100 MG TABLET
Brand
71699010030•SK Life Science, Inc.
$39.9308
per EA
XCOPRI 150 MG TABLET
Brand
71699015030•SK Life Science, Inc.
$39.9393
per EA
XCOPRI 200 MG TABLET
Brand
71699020030•SK Life Science, Inc.
$39.9414
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy